Home  >  News
Eppen_Moveit_July2026
you can get e-magazine links on WhatsApp. Click here
News
  Boehringer Ingelheim reports first-half 2026 sales growth, driven by Jardiance and new product launches in US,   July 16, 2026
  US FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy,   July 16, 2026
  Summit Therapeutics signs agreement to sell phase III asset ridinilazole to Biossil,   July 15, 2026
  US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome,   July 15, 2026
  TolerogenixX receives EMA Orphan Drug Designation for MIC-Lx, strengthening its regulatory pathway in kidney transplantation,   July 14, 2026
  Takeda and the Indonesian Government collaborate to strengthen healthcare resilience and expand access to lifesaving plasma-derived medicinal products,   July 14, 2026
  CDE of NMPA grants priority review status to Leads Biolabs’ PD-L1/4-1BB bispecific antibody, opamtistomig to treat advanced EP-NEC,   July 13, 2026
  US FDA approves Pfizer & Astellas’ Padcev plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility,   July 13, 2026
  US FDA proposes rule to modernize drug manufacturing registration,   July 13, 2026
  WuXi Biologics’ MFG8 drug substance facility secures US FDA Pre-License Inspection approval,   July 11, 2026
  CDA issues reimbursement recommendation for Empaveli to treat C3 glomerulopathy and primary IC-MPGN,   July 11, 2026
  Intas Pharma’s US specialty division, Accord BioPharma receives US FDA approval for Ennumo, a biosimilar to Neulasta,   July 11, 2026
  Bayer secures 3.0 billion euros to improve capital structure,   July 11, 2026
  Sino Biopharma’s subsidiary, CTTQ further deepens the exclusive strategic collaboration with GSK,   July 10, 2026
  Evonik to invest US$ 100 million to upgrade drug substance manufacturing site in Lafayette, Indiana,   July 10, 2026
  US FDA grants orphan drug and rare paediatric disease designations to Grünenthal’s tegacorat to treat Duchenne muscular dystrophy,   July 09, 2026
  US FDA grants breakthrough therapy designation to Merck’s enpatoran in lupus patients with active skin manifestations,   July 09, 2026
  Azenta completes sale of B Medical Systems business to Thelema,   July 09, 2026
  EMA fast tracks review of a medicine for metastatic pancreatic cancer,   July 09, 2026
  Cipher Pharma and the pan-Canadian Pharmaceutical Alliance sign LOI for public drug plan coverage of Epuris,   July 08, 2026

 Back
 
APME-2026.gif
echemi_logo26
PPPE_2026
cphi_korea2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram